D57.21 Sickle-cell/Hb-C disease with crisis

Name of the Condition

• Sickle-cell/Hb-C disease with crisis

Summary

Sickle-cell/Hb-C disease with crisis is an inherited blood disorder resulting from the co-inheritance of hemoglobin S (sickle cell) and hemoglobin C genes. This combination leads to abnormal hemoglobin, causing red blood cells to become rigid and sickle-shaped. These malformed cells can obstruct blood flow, resulting in acute vaso-occlusive episodes (crises) characterized by pain, organ damage, and other complications. The condition’s severity and clinical presentation vary, often influenced by the specific genetic interactions.

Causes

Sickle-cell/Hb-C disease arises from mutations in the hemoglobin gene (HBB). Individuals inherit one sickle cell gene (HbS) from one parent and one hemoglobin C gene (HbC) from the other. This autosomal recessive inheritance pattern means both mutated genes must be present for the disorder to manifest. The "with crisis" designation indicates the presence of acute vaso-occlusive episodes at the time of diagnosis or documentation.

Risk Factors

• Family history of sickle-cell or hemoglobin C disorders
• Ethnic background, particularly individuals of African, Mediterranean, or Caribbean descent
• Inheriting one sickle cell or hemoglobin C gene (trait) increases the risk of passing the disorder to offspring

Symptoms

• Episodes of severe pain (vaso-occlusive crises)
• Fatigue and weakness due to anemia
• Jaundice (yellowing of the skin or eyes)
• Swelling in hands and feet (dactylitis)
• Frequent infections
• Delayed growth or puberty in children

Diagnosis

Diagnosis involves blood tests to identify sickle-shaped red blood cells and hemoglobin electrophoresis to confirm the presence of both hemoglobin S and hemoglobin C. Additional tests, such as complete blood count (CBC) or genetic testing, may be used to assess severity and rule out other conditions. The "with crisis" designation is based on clinical documentation of acute vaso-occlusive episodes.

Treatment Options

Treatment focuses on managing acute crises and preventing complications. This may include pain management, hydration, and oxygen therapy during crises. Long-term management involves hydroxyurea to reduce crisis frequency, blood transfusions, and antibiotics to prevent infections. Regular monitoring and supportive care are essential.

Prognosis and Follow-Up

Prognosis varies depending on the frequency and severity of crises, as well as the presence of complications. Regular follow-up with a hematologist is recommended to monitor organ function, manage anemia, and adjust treatment. Early intervention can improve outcomes and reduce long-term damage.

Complications

• Acute chest syndrome
• Stroke
• Organ damage (e.g., spleen, kidneys, liver)
• Chronic pain
• Increased risk of infections

Lifestyle & Prevention

• Stay hydrated to reduce crisis risk
• Avoid extreme temperatures
• Manage stress and fatigue
• Follow vaccination schedules to prevent infections
• Seek prompt medical care for fever or pain

When to Seek Professional Help

Seek immediate medical attention for:

• Severe pain unrelieved by usual measures
• Signs of infection (fever, chills)
• Shortness of breath or chest pain
• Sudden weakness or confusion
• Jaundice or dark urine

Tips for Medical Coders

Document the presence of acute vaso-occlusive episodes (crises) to support the "with crisis" designation. Ensure clinical documentation specifies the occurrence of crises, as this differentiates the code from "without crisis" variants. Verify that the diagnosis aligns with genetic or laboratory confirmation of hemoglobin S and hemoglobin C co-inheritance.